We are the leading pharma tech company and the first to automate drug discovery. Our aim is to make safer, more sophisticated drugs available to all - more quickly and efficiently than ever before
At the forefront of small molecule drug discovery, We are the first company to automate drug design, surpassing conventional human endeavor. Our AI-driven systems actively learn best practices from vast repositories of discovery data and are further enhanced with knowledge acquired from seasoned drug hunters. With better information to hand than any researcher could acquire individually, our knowledge-driven systems design millions of novel, project-specific compounds and pre-assess each for predicted potency, selectivity, ADME, and other key criteria. From this, a selection of the best, information-rich compounds is selected for synthesis and assay.
B2B
26 to 50
Series C
$103,671,986
N/A
2012
Pharmaceuticals and Medical Products
Pharmaceuticals
Biotechnology
N/A
Increase Productivity
Production
IT and Security
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
N/A
Software
Data Engineer
Dundee, Scotland
Computational Drug Designer
Miami, Florida
Director Computational Drug Design
Miami, Florida
Executive Director Drug Design
Miami, Florida
Join our Miami talent pool
Miami, Florida
Want to work at Exscientia?
We can introduce you to the right person at Exscientia
10
1
$225M
Company was founded 2012 and it took almost 9 years (Apr 2021) to raise first external round
Interested in researching Exscientia?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Exscientia
Interested in what they do or partnership?
Learn more about how they work